RESULT: Reliable, Emergent Solution Using Liprotamase Treatment

Clinical trial NCT03051490 · UNKNOWN

Trial details

NCT number: NCT03051490
Sponsor: Anthera Pharmaceuticals
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Exocrine Pancreatic Insufficiency Cystic Fibrosis

Start date: 2017-04-28
Primary completion: 2018-02-28
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.